Role Of Free Bilirubin And Blood Brain Barrier In Bilirubin Neurotoxicity View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1984-04

AUTHORS

Richard P Wennberg, A James Hance

ABSTRACT

Anesthetized young adult Wistar rats were given either human serum albumin (HSA), 1.5 gm/kg, or saline, intravenously. Ten minutes later the blood brain barrier (BBB) in one hemisphere was opened by carotid artery infusion of hypertonic arabinose. Bilirubin was then infused intravenously over 8 minutes. Serial blood samples were obtained for total bilirubin (TB) and free bilirubin (FB) determinations (peroxidase method) until sacrifice 30 minutes later. Cortical EEGs were recorded continuously.Osmotic opening of the BBB resulted in yellow coloration of the affected hemisphere in both control and HSA primed animals. EEG changes, ranging from a transient decrease in amplitude to permanent cessation of electrical activity, occurred at a mean TB of 54.8±12.6 mg/dl in HSA primed rats (n=8) compared with a threshold of 30.4±6.4 mg/dl in control rats (n=11) (p<.001). At comparable TB levels, FB levels were lower in HSA primed animals. Neither EEG changes nor staining developed in animals with an intact BBB.These data suggest that yellow "staining" of brains may sometimes represent non-toxic interstitial bilirubin-albumin since neurotoxicity, as measured by EEG changes, was related to the level of FB available for binding to tissue rather than the TB level. Given a critical level of FB variations in BBB permeability to bilirubin or albumin-bilirubin may contribute to the risk for encephalopathy. More... »

PAGES

355-355

Identifiers

URI

http://scigraph.springernature.com/pub.10.1203/00006450-198404001-01570

DOI

http://dx.doi.org/10.1203/00006450-198404001-01570

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036014803


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Departments of Pediatrics and Pharmacology, University of California, Davis, California", 
          "id": "http://www.grid.ac/institutes/grid.27860.3b", 
          "name": [
            "Departments of Pediatrics and Pharmacology, University of California, Davis, California"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wennberg", 
        "givenName": "Richard P", 
        "id": "sg:person.070063300.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.070063300.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pediatrics and Pharmacology, University of California, Davis, California", 
          "id": "http://www.grid.ac/institutes/grid.27860.3b", 
          "name": [
            "Departments of Pediatrics and Pharmacology, University of California, Davis, California"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hance", 
        "givenName": "A James", 
        "id": "sg:person.01075454535.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075454535.89"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1984-04", 
    "datePublishedReg": "1984-04-01", 
    "description": "Anesthetized young adult Wistar rats were given either human serum albumin (HSA), 1.5 gm/kg, or saline, intravenously. Ten minutes later the blood brain barrier (BBB) in one hemisphere was opened by carotid artery infusion of hypertonic arabinose. Bilirubin was then infused intravenously over 8 minutes. Serial blood samples were obtained for total bilirubin (TB) and free bilirubin (FB) determinations (peroxidase method) until sacrifice 30 minutes later. Cortical EEGs were recorded continuously.Osmotic opening of the BBB resulted in yellow coloration of the affected hemisphere in both control and HSA primed animals. EEG changes, ranging from a transient decrease in amplitude to permanent cessation of electrical activity, occurred at a mean TB of 54.8\u00b112.6 mg/dl in HSA primed rats (n=8) compared with a threshold of 30.4\u00b16.4 mg/dl in control rats (n=11) (p<.001). At comparable TB levels, FB levels were lower in HSA primed animals. Neither EEG changes nor staining developed in animals with an intact BBB.These data suggest that yellow \"staining\" of brains may sometimes represent non-toxic interstitial bilirubin-albumin since neurotoxicity, as measured by EEG changes, was related to the level of FB available for binding to tissue rather than the TB level. Given a critical level of FB variations in BBB permeability to bilirubin or albumin-bilirubin may contribute to the risk for encephalopathy.", 
    "genre": "article", 
    "id": "sg:pub.10.1203/00006450-198404001-01570", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1007352", 
        "issn": [
          "0031-3998", 
          "1530-0447"
        ], 
        "name": "Pediatric Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "blood-brain barrier", 
      "EEG changes", 
      "brain barrier", 
      "intact blood-brain barrier", 
      "TB levels", 
      "young adult Wistar rats", 
      "carotid artery infusion", 
      "Serial blood samples", 
      "adult Wistar rats", 
      "human serum albumin", 
      "hypertonic arabinose", 
      "affected hemisphere", 
      "albumin-bilirubin", 
      "BBB permeability", 
      "osmotic opening", 
      "control rats", 
      "Wistar rats", 
      "cortical EEG", 
      "blood samples", 
      "permanent cessation", 
      "bilirubin neurotoxicity", 
      "transient decrease", 
      "levels of FB", 
      "FB levels", 
      "rats", 
      "bilirubin", 
      "electrical activity", 
      "gm/", 
      "neurotoxicity", 
      "dl", 
      "free bilirubin", 
      "bilirubin determination", 
      "minutes", 
      "animals", 
      "serum albumin", 
      "albumin", 
      "levels", 
      "infusion", 
      "saline", 
      "brain", 
      "cessation", 
      "staining", 
      "risk", 
      "hemisphere", 
      "tissue", 
      "changes", 
      "TB", 
      "EEG", 
      "barriers", 
      "mean Tb", 
      "decrease", 
      "control", 
      "activity", 
      "role", 
      "critical level", 
      "FB", 
      "threshold", 
      "yellow coloration", 
      "samples", 
      "data", 
      "permeability", 
      "opening", 
      "amplitude", 
      "determination", 
      "variation", 
      "arabinose", 
      "coloration"
    ], 
    "name": "ROLE OF FREE BILIRUBIN AND BLOOD BRAIN BARRIER IN BILIRUBIN NEUROTOXICITY", 
    "pagination": "355-355", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036014803"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1203/00006450-198404001-01570"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1203/00006450-198404001-01570", 
      "https://app.dimensions.ai/details/publication/pub.1036014803"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_178.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1203/00006450-198404001-01570"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1203/00006450-198404001-01570'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1203/00006450-198404001-01570'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1203/00006450-198404001-01570'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1203/00006450-198404001-01570'


 

This table displays all metadata directly associated to this object as RDF triples.

132 TRIPLES      21 PREDICATES      93 URIs      85 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1203/00006450-198404001-01570 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author N13ff2d13d45345d390c7f1878f00085e
4 schema:datePublished 1984-04
5 schema:datePublishedReg 1984-04-01
6 schema:description Anesthetized young adult Wistar rats were given either human serum albumin (HSA), 1.5 gm/kg, or saline, intravenously. Ten minutes later the blood brain barrier (BBB) in one hemisphere was opened by carotid artery infusion of hypertonic arabinose. Bilirubin was then infused intravenously over 8 minutes. Serial blood samples were obtained for total bilirubin (TB) and free bilirubin (FB) determinations (peroxidase method) until sacrifice 30 minutes later. Cortical EEGs were recorded continuously.Osmotic opening of the BBB resulted in yellow coloration of the affected hemisphere in both control and HSA primed animals. EEG changes, ranging from a transient decrease in amplitude to permanent cessation of electrical activity, occurred at a mean TB of 54.8±12.6 mg/dl in HSA primed rats (n=8) compared with a threshold of 30.4±6.4 mg/dl in control rats (n=11) (p<.001). At comparable TB levels, FB levels were lower in HSA primed animals. Neither EEG changes nor staining developed in animals with an intact BBB.These data suggest that yellow "staining" of brains may sometimes represent non-toxic interstitial bilirubin-albumin since neurotoxicity, as measured by EEG changes, was related to the level of FB available for binding to tissue rather than the TB level. Given a critical level of FB variations in BBB permeability to bilirubin or albumin-bilirubin may contribute to the risk for encephalopathy.
7 schema:genre article
8 schema:inLanguage en
9 schema:isAccessibleForFree true
10 schema:isPartOf N5f54304fa1af466f9553e53b065ab2a3
11 Nf5a3db4a482048c08ef22cc8b37535fb
12 sg:journal.1007352
13 schema:keywords BBB permeability
14 EEG
15 EEG changes
16 FB
17 FB levels
18 Serial blood samples
19 TB
20 TB levels
21 Wistar rats
22 activity
23 adult Wistar rats
24 affected hemisphere
25 albumin
26 albumin-bilirubin
27 amplitude
28 animals
29 arabinose
30 barriers
31 bilirubin
32 bilirubin determination
33 bilirubin neurotoxicity
34 blood samples
35 blood-brain barrier
36 brain
37 brain barrier
38 carotid artery infusion
39 cessation
40 changes
41 coloration
42 control
43 control rats
44 cortical EEG
45 critical level
46 data
47 decrease
48 determination
49 dl
50 electrical activity
51 free bilirubin
52 gm/
53 hemisphere
54 human serum albumin
55 hypertonic arabinose
56 infusion
57 intact blood-brain barrier
58 levels
59 levels of FB
60 mean Tb
61 minutes
62 neurotoxicity
63 opening
64 osmotic opening
65 permanent cessation
66 permeability
67 rats
68 risk
69 role
70 saline
71 samples
72 serum albumin
73 staining
74 threshold
75 tissue
76 transient decrease
77 variation
78 yellow coloration
79 young adult Wistar rats
80 schema:name ROLE OF FREE BILIRUBIN AND BLOOD BRAIN BARRIER IN BILIRUBIN NEUROTOXICITY
81 schema:pagination 355-355
82 schema:productId N8ae959c728094609ac0ba1212bc7c6e7
83 Nd11a7b2779614532996816e5afaeb89d
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036014803
85 https://doi.org/10.1203/00006450-198404001-01570
86 schema:sdDatePublished 2022-05-20T07:18
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher Nd3e40c407d3b4cf38d87a94b485e73fc
89 schema:url https://doi.org/10.1203/00006450-198404001-01570
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N13ff2d13d45345d390c7f1878f00085e rdf:first sg:person.070063300.96
94 rdf:rest N226db655cefa4f8587cf584151431aa8
95 N226db655cefa4f8587cf584151431aa8 rdf:first sg:person.01075454535.89
96 rdf:rest rdf:nil
97 N5f54304fa1af466f9553e53b065ab2a3 schema:volumeNumber 18
98 rdf:type schema:PublicationVolume
99 N8ae959c728094609ac0ba1212bc7c6e7 schema:name doi
100 schema:value 10.1203/00006450-198404001-01570
101 rdf:type schema:PropertyValue
102 Nd11a7b2779614532996816e5afaeb89d schema:name dimensions_id
103 schema:value pub.1036014803
104 rdf:type schema:PropertyValue
105 Nd3e40c407d3b4cf38d87a94b485e73fc schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 Nf5a3db4a482048c08ef22cc8b37535fb schema:issueNumber Suppl 4
108 rdf:type schema:PublicationIssue
109 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
110 schema:name Medical and Health Sciences
111 rdf:type schema:DefinedTerm
112 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
113 schema:name Neurosciences
114 rdf:type schema:DefinedTerm
115 sg:journal.1007352 schema:issn 0031-3998
116 1530-0447
117 schema:name Pediatric Research
118 schema:publisher Springer Nature
119 rdf:type schema:Periodical
120 sg:person.01075454535.89 schema:affiliation grid-institutes:grid.27860.3b
121 schema:familyName Hance
122 schema:givenName A James
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075454535.89
124 rdf:type schema:Person
125 sg:person.070063300.96 schema:affiliation grid-institutes:grid.27860.3b
126 schema:familyName Wennberg
127 schema:givenName Richard P
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.070063300.96
129 rdf:type schema:Person
130 grid-institutes:grid.27860.3b schema:alternateName Departments of Pediatrics and Pharmacology, University of California, Davis, California
131 schema:name Departments of Pediatrics and Pharmacology, University of California, Davis, California
132 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...